Inventor · disambiguated record
Larry Green
Also filed as: GREEN LARRY · GREEN LARRY L
71 granted patents·22 pending applications·2,071 citations·filing 1999–2022
99Inventor score
Top patents by PatentIndex Score
93 records- 0198US10836832B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Nov 17, 2020·6 cites·27 claims
- 0297US10829564B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Nov 10, 2020·4 cites·29 claims
- 0397US10494445B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Dec 3, 2019·10 cites·12 claims
- 0497US9580491B2Genetic engineering of non-human animals for the production of chimeric antibodiesGREEN LARRY·Filed 2011·Granted Feb 28, 2017·36 cites·13 claims
- 0597US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 0697US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 0797US7435871B2Transgenic animals bearing human Igλ light chain genesAMGEN FREMONT INC·Filed 2002·Granted Oct 14, 2008·173 cites·9 claims
- 0897US7064244B2Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefromABGENIX INC·Filed 2002·Granted Jun 20, 2006·197 cites·6 claims
- 0997US7049426B2Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regionsABGENIX INC·Filed 2001·Granted May 23, 2006·162 cites·16 claims
- 1097US6833268B1Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regionsABGENIX INC·Filed 1999·Granted Dec 21, 2004·211 cites·4 claims
- 1196US10604587B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Mar 31, 2020·7 cites·19 claims
- 1296US10526420B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Jan 7, 2020·10 cites·18 claims
- 1396US8470330B2PSMA antibodies and uses thereofMADDON PAUL J·Filed 2010·Granted Jun 25, 2013·50 cites·31 claims
- 1496US7705130B2Antibodies directed to HER-3 and uses thereofU3 PHARMA GMBH·Filed 2007·Granted Apr 27, 2010·84 cites·29 claims
- 1596US7566772B2Antibodies against interleukin-1βAMGEN FREMONT INC·Filed 2006·Granted Jul 28, 2009·72 cites·19 claims
- 1695US10618977B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Apr 14, 2020·5 cites·28 claims
- 1795US10575504B2Non-human mammals for the production of chimeric antibodiesABLEXIS LLC·Filed 2016·Granted Mar 3, 2020·7 cites·13 claims
- 1895US9346873B2Non-human mammals for the production of chimeric antibodiesGREEN LARRY·Filed 2009·Granted May 24, 2016·27 cites·11 claims
- 1995US8114965B2Compositions of PSMA antibodiesMADDON PAUL J·Filed 2007·Granted Feb 14, 2012·52 cites·47 claims
- 2095US7973140B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2005·Granted Jul 5, 2011·36 cites·11 claims
- 2195US7285269B2Antibodies directed to tumor necrosis factorAMGEN FREMONT INC·Filed 2003·Granted Oct 23, 2007·101 cites·35 claims
- 2295US7067131B2Methods for using anti-MUC18 antibodiesABGENIX INC·Filed 2002·Granted Jun 27, 2006·61 cites·21 claims
- 2395US6924360B2Antibodies against the MUC18 antigenABGENIX INC·Filed 2002·Granted Aug 2, 2005·79 cites·57 claims
- 2494US10662255B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted May 26, 2020·5 cites·27 claims
- 2594US10626188B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Apr 21, 2020·5 cites·22 claims
- 2694US7964193B2Antibodies against interleukin-1 βAMGEN FREMONT INC·Filed 2009·Granted Jun 21, 2011·29 cites·12 claims
- 2794US7932372B2Antibodies to MAdCAMAMGEN FREMONT INC·Filed 2006·Granted Apr 26, 2011·30 cites·52 claims
- 2893US10492476B2Non-human mammals for the production of chimeric antibodiesABLEXIS LLC·Filed 2016·Granted Dec 3, 2019·5 cites·10 claims
- 2993US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 3093US7547817B2Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regionsAMGEN FREMONT INC·Filed 2005·Granted Jun 16, 2009·25 cites·26 claims
- 3193US7498420B2Antibodies to c-MetAMGEN FREMONT INC·Filed 2004·Granted Mar 3, 2009·60 cites·34 claims
- 3292US7807159B2Antibodies to myostatinAMGEN FREMONT INC·Filed 2006·Granted Oct 5, 2010·102 cites·14 claims
- 3391US7968684B2IL-18 binding proteinsABBOTT LAB·Filed 2004·Granted Jun 28, 2011·24 cites·64 claims
- 3491US7090844B2Use of antibodies against the MUC18 antigenABGENIX INC·Filed 2003·Granted Aug 15, 2006·48 cites·27 claims
- 3590US8821869B2Treatment methods using c-Met antibodiesAMGEN FREMONT INC·Filed 2013·Granted Sep 2, 2014·13 cites·15 claims
- 3690US8809051B2Transgenic mammals having human Ig loci including plural VH and Vκ regions and antibodies produced therefromJAKOBOVITS AYA·Filed 2007·Granted Aug 19, 2014·16 cites·18 claims
- 3790US8562985B2Antibodies to c-MetMICHAUD NEIL R·Filed 2012·Granted Oct 22, 2013·15 cites·21 claims
- 3889US11104743B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Aug 31, 2021·1 cites·20 claims
- 3988US11104744B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Aug 31, 2021·1 cites·20 claims
- 4088US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 4188US8710191B2Antibodies to CCR2GLADUE RONALD P·Filed 2009·Granted Apr 29, 2014·21 cites·11 claims
- 4285US10555506B2Non-human mammals for the production of chimeric antibodiesABLEXIS LLC·Filed 2016·Granted Feb 11, 2020·2 cites·12 claims
- 4385US8163280B2Antibodies to c-MetMICHAUD NEIL R·Filed 2009·Granted Apr 24, 2012·8 cites·18 claims
- 4485US7396913B2Erythropoietin receptor binding antibodiesABBOTT LAB·Filed 2003·Granted Jul 8, 2008·12 cites·11 claims
- 4584US8834880B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2012·Granted Sep 16, 2014·5 cites·4 claims
- 4683US7625549B2Determining the risk of human anti-human antibodies in transgenic miceAMGEN FREMONT INC·Filed 2005·Granted Dec 1, 2009·3 cites·24 claims
- 4782US9073998B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Jul 7, 2015·3 cites·88 claims
- 4881US11492411B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2019·Granted Nov 8, 2022·0 cites·20 claims
- 4981US10118968B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Nov 6, 2018·2 cites·54 claims
- 5081US7820877B2Transgenic mammals having human IG loci including plural Vh and Vk regions and antibodies produced therefromAMGEN FREMONT INC·Filed 2005·Granted Oct 26, 2010·3 cites·10 claims
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Larry Green files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →